ImClone Systems LLC

ImClone Systems LLC is a biopharmaceutical company. The Company develops and commercializes a portfolio of targeted treatments designed to address the medical needs of patients with cancer. ImClone's research and development programs include growth factor blockers and angiogenesis inhibitors.